No Data
Open H, Ship HD, etc. (additional) Rating
Upgrades - bullish Code Stock Name Brokerage Firm Previous After ------------------------------------------------------------- <2413> M3 City "2" "1" <4565> Nexela Pharmacy City "2" "1" <7269> Suzuki JPM "Neutral" "Overweight" Downgrades - bearish Code Stock Name Brokerage Firm Previous After --------------------------
Rating [security companies rating]
Upgraded - bullish code stock name securities company old change after--------------------------------------------------------------<3110> Nitto Boseki Tokai Tokyo "neutral" "outperform" <9005> Tokyu SBI "hold" "buy" <7269> Suzuki JP Morgan "neutral" "overweight" <2413> M3 City "hold" "buy" <4565> Nexela P City "hold" "
Express News | Nxera Pharma’s Partner Centessa Initiates Phase 2 Trial With Orx750, a Novel Orexin Receptor 2 (Ox2R) Agonist
Nxera Pharma Gains Milestone Payment in Sleep Disorder Collaboration
Stocks that moved on the previous day part2 include Japan Ham, Taiyo Koki, Fuji Kogaku E&C, etc.
Stock name <Code> 5-day closing price ⇒ Day-to-day comparison BIPROGY <8056> 4420 -3187- The 9-month period is expected to turn into a decrease in ordinary income. Nippon Ham <2282> 4754 -516 Negative sentiment such as sluggish improvement in processing business income. Tokyo Electron Devices <2760> 3065 -265 Half-year double-digit operating income decline results are also disappointing. Rigaku <268A> 1200 -50 Will selling pressure prevail due to awareness of resistance at the upper end? Nexera Pharma <4565> 1174 -397 -9
Express News | Nxera Pharma and Antiverse Enter Collaboration to Design Novel Gpcr-Targeted Antibody Therapeutics Using Generative AI
No Data
No Data